NM_017636.4:c.856A>G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017636.4(TRPM4):c.856A>G(p.Thr286Ala) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,613,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/25 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_017636.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 151720Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251420Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135900
GnomAD4 exome AF: 0.000122 AC: 179AN: 1461878Hom.: 0 Cov.: 32 AF XY: 0.000140 AC XY: 102AN XY: 727242
GnomAD4 genome AF: 0.000138 AC: 21AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74212
ClinVar
Submissions by phenotype
Progressive familial heart block type IB Uncertain:2
This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 286 of the TRPM4 protein (p.Thr286Ala). This variant is present in population databases (rs151205002, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with TRPM4-related conditions. ClinVar contains an entry for this variant (Variation ID: 578268). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not provided Uncertain:1
Identified in a patient with Sudden Infant Death syndrome (SIDS) who also harbored the c.1690_1692dupCTT variant in the TRPM4 gene (Campuzano et al., 2018); At the protein level, in silico analysis supports that this missense variant does not alter protein structure/function; In silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 30086531) -
Cardiovascular phenotype Uncertain:1
The p.T286A variant (also known as c.856A>G), located in coding exon 7 of the TRPM4 gene, results from an A to G substitution at nucleotide position 856. The threonine at codon 286 is replaced by alanine, an amino acid with similar properties. This alteration has been reported in a sudden infant death syndrome (SIDS) cohort (Campuzano O et al. Forensic Sci Int Genet, 2018 Nov;37:54-63). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not specified Benign:1
Variant summary: TRPM4 c.856A>G (p.Thr286Ala) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00019 in 251420 control chromosomes, predominantly at a frequency of 0.00029 within the Latino subpopulation in the gnomAD database. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 116 fold of the estimated maximal expected allele frequency for a pathogenic variant in TRPM4 causing Progressive Familial Heart Block Type 1B phenotype (2.5e-06). c.856A>G has been reported in the literature in individuals affected with TRPM4-related disorders as well as in controls (Couthouis_2014, Campuzano_2018). These reports do not provide unequivocal conclusions about association of the variant with Progressive Familial Heart Block Type 1B. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30086531, 25299611). ClinVar contains an entry for this variant (Variation ID: 578268). Based on the evidence outlined above, the variant was classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at